A detailed history of Hantz Financial Services, Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Hantz Financial Services, Inc. holds 219,718 shares of TAK stock, worth $3.04 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
219,718
Holding current value
$3.04 Million
% of portfolio
0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$12.6 - $13.67 $2.77 Million - $3 Million
219,718 New
219,718 $2.84 Million
Q1 2024

Aug 06, 2024

BUY
$13.89 - $15.04 $45,809 - $49,601
3,298 Added 1.45%
230,555 $3.2 Million
Q4 2023

Aug 06, 2024

SELL
$13.36 - $15.43 $103,165 - $119,150
-7,722 Reduced 3.29%
227,257 $3.24 Million
Q3 2023

Aug 06, 2024

BUY
$15.03 - $16.32 $50,846 - $55,210
3,383 Added 1.46%
234,979 $3.64 Million
Q2 2023

Aug 06, 2024

SELL
$15.57 - $17.11 $5,231 - $5,748
-336 Reduced 0.14%
231,596 $3.64 Million
Q1 2023

Aug 06, 2024

BUY
$15.28 - $16.48 $687 - $741
45 Added 0.02%
231,932 $3.82 Million
Q4 2022

Aug 06, 2024

SELL
$12.42 - $15.62 $63,354 - $79,677
-5,101 Reduced 2.15%
231,887 $3.62 Million
Q3 2022

Aug 06, 2024

BUY
$12.8 - $28.65 $49,459 - $110,703
3,864 Added 1.66%
236,988 $3.07 Million
Q2 2022

Aug 06, 2024

BUY
$13.12 - $15.03 $123,839 - $141,868
9,439 Added 4.22%
233,124 $3.27 Million
Q1 2022

Aug 06, 2024

BUY
$13.54 - $15.35 $575,802 - $652,774
42,526 Added 23.47%
223,685 $3.2 Million
Q4 2021

Aug 06, 2024

BUY
$13.17 - $16.4 $176,688 - $220,022
13,416 Added 8.0%
181,159 $2.47 Million
Q3 2021

Aug 06, 2024

BUY
$16.3 - $17.26 $491,216 - $520,147
30,136 Added 21.9%
167,743 $2.75 Million
Q2 2021

Aug 06, 2024

BUY
$16.55 - $18.64 $364,431 - $410,452
22,020 Added 19.05%
137,607 $2.32 Million
Q1 2021

Aug 06, 2024

SELL
$16.71 - $19.9 $1.74 Million - $2.07 Million
-104,131 Reduced 47.39%
115,587 $2.11 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Hantz Financial Services, Inc. Portfolio

Follow Hantz Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hantz Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hantz Financial Services, Inc. with notifications on news.